Dr. Frijlink received his pharmaceutical training at the University of Groningen (The Netherlands), where he received his Ph.D. degree in Pharmaceutical Technology. He served for two years as a pharmacist in the Martini Hospital (Groningen, Nl). From 1992 to 1997 he was project leader and head of the Pharmaceutical Development Department of Solvay Pharmaceuticals. Since 1998 Dr. Frijlink is Professor at the Department of Pharmaceutical Technology and Biopharmacy of the Groningen Research Institute of Pharmacy. The main interests of his current research are technical and biopharmaceutical aspects of pulmonary drug delivery and the development of dry powder inhalers. The formulation of biopharmaceuticals such as peptides, proteins, vaccines and gene based products using stabilizing sugar glasses is a further research topic in his department. He is interested in solid oral dosage forms, their technological and biopharmaceutical aspects and gastro-intestinal targeting strategies. Finally, he is interested in development, scale up and quality aspects of pharmaceutical production. From 2016 to 2021 Dr. Frijlink was Director of the Groningen Research Institute of Pharmacy and deputy director of the Groningen University Institute for Drug Exploration.